Keros Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold KROS, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

19
Funds holding
$46456794
Total value held
Buying
11 added/new · 8 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $26626189 2411793 +121261 +5.29%
2 State Street Corp $6201499 561730 -514263 -47.79%
3 Northern Trust Corp $2806224 254187 +3616 +1.44%
4 Goldman Sachs Group Inc $2478248 224479 -366038 -61.99%
5 Invesco Ltd. $1780034 87428 +12449 +16.60%
6 Morgan Stanley $1370206 124112 -106380 -46.15%
7 Bank Of New York Mellon Corp $1335221 120944 -638 -0.52%
8 Ameriprise Financial Inc $1131368 102479 -20349 -16.57%
9 Wells Fargo & Company/Mn $667034 32762 +6872 +26.54%
10 Principal Financial Group Inc $657918 59594 NEW BUY
11 Bank Of America Corp /De/ $592340 53654 -46460 -46.41%
12 Barclays Plc $255652 23157 NEW BUY
13 Franklin Resources Inc $240186 21756 -5826 -21.12%
14 Citigroup Inc $144739 7109 +4192 +143.71%
15 American Financial Group Inc $111559 10105 NEW BUY
16 Royal Bank Of Canada $54000 4867 NEW BUY
17 Pnc Financial Services Group, Inc. $3853 349 +32 +10.09%
18 Us Bancorp \De\ $386 35 -499 -93.45%
19 Amalgamated Financial Corp. $138 2542 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.